Demographics (4)
- AGE - Subject age at enrollment (phv00509011.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00509026.v1.p1)
- SEX - Self-reported sex (phv00509012.v1.p1)
- SEX - Biological sex (phv00509007.v1.p1)
Disease Events (5)
- SURVIVAL_MONTHS - Survival in months (phv00509019.v1.p1)
- SURVIVED_BEYOND_DAYS - Survival calculated based on last note on patient chart (exact death date unknown) (phv00509020.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00509030.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00509029.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00509031.v1.p1)
Medications (1)
- STEROIDS_BEFORE_SURGERY - Treatment with steroids prior to sample collection (phv00509018.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00509013.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00509023.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00509022.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00509006.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00509025.v1.p1)
- IS_TUMOR - Tumor status (phv00509024.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00509027.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00509028.v1.p1)
- SAMPLE_ID - Sample ID (phv00509021.v1.p1)
- SAMPLE_ID - Sample ID (phv00509009.v1.p1)
- SUBJECT_ID - Subject ID (phv00509010.v1.p1)
- SUBJECT_ID - Subject ID (phv00509005.v1.p1)
- SUBJECT_ID - Subject ID (phv00509008.v1.p1)
- TUMOR_CLASS - Classification based on odds ratio (OR) for EGFR/CDK4 co-amplification (phv00509017.v1.p1)
- TUMOR_HEMISPHERE - Location of the tumor - hemisphere (phv00509015.v1.p1)
- TUMOR_HISTOLOGY - Histological classification of the tumor (phv00509014.v1.p1)
- TUMOR_LOCATION - Location of the tumor - lobe (phv00509016.v1.p1)